The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Changing trends in etiology‐based annual mortality from chronic liver disease, from 2007 through 2016
Open accessAbstract
Background & aims Although treatment of hepatitis C virus (HCV) infection has improved, the prevalence of alcoholic liver disease (ALD) has been increasing, so we need an updated estimate of the burden and etiology-specific mortality of chronic liver diseases. We studied trends in age-standardized mortality of chronic liver diseases in adults at least 20 years old in the United States from 2007 through 2016.Methods We collected data from the US Census and National Center for Health Statistics mortality records and identified individuals with HCV infection, ALD, nonalcoholic fatty liver disease, or hepatitis B virus infection using ICD-10 codes. We obtained temporal mortality rate patterns using joinpoint trend analysis with estimates of annual percentage change (APC).Results Age-standardized HCV-related mortality increased from 7.17 per 100,000 persons in 2007 to 8.14 per 100,000 persons in 2013, followed by a marked decrease in the time period at which patients began receiving treatment with direct-acting antiviral agents (from 8.09 per 100,000 persons in 2014 to 7.15 per 100,000 persons in 2016). The APC in HCV mortality increased 2.0%/year from 2007 through 2014 but decreased 6.4%/year from 2014 through 2016. In contrast, age-standardized mortality increased for ALD (APC 2.3% from 2007 through 2013 and APC 5.5% from 2013 through 2016) and nonalcoholic fatty liver disease (APC 6.1% from 2007 through 2013 and APC 11.3% from 2013 through 2016). Mortality related to hepatitis B virus decreased steadily from 2007 through 2016, with an average APC of -2.1% (95% CI -3.0 to -1.2). Etiology-based mortality in minority populations was higher. HCV-related mortality (per 100,000 persons) was highest in non-Hispanic blacks (10.28) and whites (6.92), followed by Hispanics (5.94), and lowest in non-Hispanic Asians (2.33). Non-Hispanic Asians had higher mortality for hepatitis B virus infection (2.82 per 100,000 vs 1.02 for non-Hispanic blacks and 0.47 for non-Hispanic whites).Conclusion In our population-based analysis of chronic liver disease mortality in the United States, the decrease in HCV-related mortality coincided with the introduction of direct-acting antiviral therapies, whereas mortality from ALD and nonalcoholic fatty liver disease increased during the same period. Minorities in the United States have disproportionately higher mortality related to chronic liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, CLD is uniquely associated with complex psychosocial comorbidities, including alcohol use disorder (increasingly among the young population)7, 8 and substance abuse, both of which occur more frequently and at a greater severity among patients with CLD than the general population.9”
From A Behavioral Health Program for Alcohol Use Disorder, Substance Abuse, and Depression in Chronic Liver Disease (2019) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
Wong, R. J., Aguilar, M. E. F., Cheung, R. C., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.11.039 · Cited by 1,861
Self-citationvan der Meer, A. J., Veldt, B. J., Feld, J. J., Wedemeyer, H. H., Dufour, J., Lammert, F., Duarte‐Rojo, A., Heathcote, E. J., Manns, M. P., Kuske, L., et al. (2012) · JAMA · doi:10.1001/jama.2012.144878 · Cited by 1,507
Panel, A. I. H. G. (2015) · Hepatology · doi:10.1002/hep.27950 · Cited by 1,385
Stanaway, J. D., Flaxman, A. D., Naghavi, M., Fitzmaurice, C., Vos, T., Abubakar, I., Abu-Raddad, L. J., Assadi, R., Bhala, N. B., Cowie, B., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30579-7 · Cited by 1,350
Estimating average annual per cent change in trend analysis
Clegg, L. X., Hankey, B. F., Tiwari, R. C., Feuer, E. J., & Edwards, B. K. (2009) · Statistics in Medicine · doi:10.1002/sim.3733 · Cited by 1,271
Younossi, Z. M., Stepanova, M., Afendy, M., Fang, Y. H., Younossi, Y., Mir, H., & Srishord, M. K. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.020 · Cited by 1,072
Davis, G. L., Alter, M. J., El‐Serag, H. B., Poynard, T., & Jennings, L. W. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.067 · Cited by 879
Charlton, M., Everson, G. T., Flamm, S. L., Kumar, P. N., Landis, C. S., Brown, R. S., Fried, M. W., Terrault, N. A., O’Leary, J. G., Vargas, H. E., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.010 · Cited by 799
Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
Self-citation
Cited by
Sorted by citations
Non-alcoholic fatty liver disease - a global public health perspective
Younossi, Z. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.033 · Cited by 2,149
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Pοlyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2018) · Metabolism · doi:10.1016/j.metabol.2018.11.014 · Cited by 1,264
Peery, A. F., Crockett, S. D., Murphy, C. C., Jensen, E. T., Kim, H. P., Egberg, M. D., Lund, J. L., Moon, A. M., Pate, V., Barnes, E. L., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.10.017 · Cited by 841
Global Epidemiology of Chronic Liver Disease
Cheemerla, S., & Balakrishnan, M. (2021) · Clinical Liver Disease · doi:10.1002/cld.1061 · Cited by 571
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population
Graupera, I., Thiele, M. S., Serra‐Burriel, M., Caballería, L., Roulot, D. M., Wong, G. L., Fabrellas, N., Guha, I. N., Arslanow, A., Expósito, C., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.034 · Cited by 302
Zou, B., Yeo, Y. H., Nguyen, V. H., Cheung, R. C., Ingelsson, E., & Nguyen, M. H. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13069 · Cited by 250
Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults
Hirode, G., Saab, S., & Wong, R. J. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.1997 · Cited by 246
Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
Nguyen, V. H., Le, M. H., Cheung, R. C., & Nguyen, M. H. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.05.029 · Cited by 217
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting
Avila, M. A., Dufour, J., Gerbes, A. L., Zoulim, F., Bataller, R. A., Burra, P., Cortez‐Pinto, H., Gao, B., Gilmore, I. T., Mathurin, P., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-319720 · Cited by 210
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
Trebicka, J., Bork, P., Krag, A. A., & Arumugam, M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00376-3 · Cited by 204
The Epidemiology of Hepatocellular Carcinoma in the USA
Kim, H., & El‐Serag, H. B. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0681-x · Cited by 161
Rasmussen, D. N., Thiele, M. S., Johansen, S., Kjærgaard, M., Lindvig, K. P., Israelsen, M. E., Antonsen, S., Detlefsen, S., Krag, A. A., Anastasiadou, E., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.037 · Cited by 150
Cunningham, E. B., Wheeler, A., Hajarizadeh, B., French, C. E., Roche, R., Marshall, A. D., Fontaine, G., Conway, A., Valencia, B. M., Bajis, S., et al. (2022) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00471-4 · Cited by 150
Aghemo, A., Alekseeva, O. P., Angelico, F., Бакулин, И. Г., Бакулина, Н. В., Bordin, D. S., Bueverov, A. O., Drapkina, O. M., Gillessen, A., Kagarmanova, E. M., et al. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2069854 · Cited by 138
Recent Epidemiology of Nonalcoholic Fatty Liver Disease
Murag, S., Ahmed, A., & Kim, D. (2020) · Gut and Liver · doi:10.5009/gnl20127 · Cited by 127
Self-citationGe, J., Pletcher, M. J., Lai, J. C., Harper, J. R., Chute, C. G., & Haendel, M. A. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.010 · Cited by 109
Alavi, M., Law, M. G., Valerio, H., Grebely, J., Amin, J., Hajarizadeh, B., Selvey, C., George, J., & Dore, G. J. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.014 · Cited by 103
Depression is associated with non‐alcoholic fatty liver disease among adults in the United States
Kim, D., Yoo, E. R., Li, A. A., Tighe, S. P., Cholankeril, G. T., Harrison, S. A., & Ahmed, A. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15395 · Cited by 102
Self-citationImpact of the COVID-19 pandemic on liver disease-related mortality rates in the United States
Gao, X., Lv, F., He, X., Zhao, Y., Liu, Y., Zu, J., Henry, L. L., Wang, J., Yeo, Y. H., Ji, F., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.07.028 · Cited by 103
Israelsen, M. E., Juel, H. B., Detlefsen, S., Madsen, B. S., Rasmussen, D. N., Larsen, T. R., Kjærgaard, M., Jensen, M. J. F., Stender, S., Hansen, T. F., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.11.038 · Cited by 99
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
Konyn, P., Ahmed, A., & Kim, D. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0351 · Cited by 100
Self-citationDai, X.-M., Feng, J., Chen, Y., Huang, S., Shi, X., Liu, X., & Sun, Y. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00469-4 · Cited by 102
Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century
Moon, A. M., Yang, J. Y., Barritt, A. S., Bataller, R. A., & Peery, A. F. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000442 · Cited by 88
Grebely, J., Tran, L. T., Degenhardt, L. J., Dowell‐Day, A., Santo, T., Larney, S., Hickman, M., Vickerman, P. T., French, C. E., Butler, K., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa612 · Cited by 82
Kim, D., Kim, W. K., Adejumo, A., Cholankeril, G. T., Tighe, S. P., Wong, R. J., Gonzalez, S. A., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2019) · Hepatology International · doi:10.1007/s12072-018-09926-z · Cited by 81
Self-citationKim, D., Adejumo, A., Yoo, E. R., Iqbal, U., Li, A. A., Pham, E. A., Cholankeril, G. T., Glenn, J. S., & Ahmed, A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.06.026 · Cited by 77
Self-citationPaik, J. M., Golabi, P., Biswas, R., Alqahtani, S. A., Venkatesan, C., & Younossi, Z. M. (2020) · Hepatology Communications · doi:10.1002/hep4.1510 · Cited by 76
Golabi, P., Paik, J. M., Eberly, K. E., de Avila, L., Alqahtani, S. A., & Younossi, Z. M. (2021) · Annals of Hepatology · doi:10.1016/j.aohep.2021.100556 · Cited by 76
Marshall, A. D., Willing, A., Kairouz, A., Cunningham, E. B., Wheeler, A., O’Brien, N., Perera, V., Ward, J. W., Hiebert, L., Degenhardt, L. J., et al. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00335-7 · Cited by 78
Current epidemiology of chronic liver disease
Manikat, R., Ahmed, A., & Kim, D. (2023) · Gastroenterology report · doi:10.1093/gastro/goae069 · Cited by 70
Self-citationChronic Liver Disease and Silymarin: A Biochemical and Clinical Review
Tighe, S. P., Akhtar, D. H., Iqbal, U., & Ahmed, A. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00012 · Cited by 64
Self-citationA Comparative Analysis of Machine Learning Algorithms to Predict Liver Disease
Ghosh, M., Raihan, M. M. S., Raihan, M., Akter, L., Bairagi, A. K., Alshamrani, S. S., & Masud, M. (2021) · Intelligent Automation & Soft Computing · doi:10.32604/iasc.2021.017989 · Cited by 63
Nagai, S., Collins, K., Chau, L. C., Safwan, M., Rizzari, M. D., Yoshida, A., Abouljoud, M. S., & Moonka, D. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.04.033 · Cited by 60
Israelsen, M. E., Kim, M. G., Suvitaival, T., Madsen, B. S., Hansen, C. D., Torp, N., Trôst, K., Thiele, M. S., Hansen, T. F., Legido‐Quigley, C., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100325 · Cited by 57
Pennisi, G., Celsa, C., Giammanco, A., Spatola, F., & Petta, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225613 · Cited by 52
Alferink, L. J. M., Erler, N. S., de Knegt, R. J., Janssen, H. L. A., Metselaar, H. J., Murad, S. D., & Jong, J. C. K. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00627-2 · Cited by 56
Alcohol-Associated Liver Disease Mortality
Pan, C., Abboud, Y., Chitnis, A. S., Zhang, W., Singal, A. K., & Wong, R. J. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.14857 · Cited by 50
He, H., Peng, S., Song, X., Jia, R., Zou, Y., Li, L., & Yin, Z. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2668 · Cited by 49
Li, S., Saviano, A., Erstad, D. J., Hoshida, Y., Fuchs, B. C., Baumert, T., & Tanabe, K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123817 · Cited by 46
Kim, D., Alshuwaykh, O. S., Dennis, B. B., Cholankeril, G. T., & Ahmed, A. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.05.045 · Cited by 49
Self-citationAlcohol-related liver disease: Time for action
Bataller, R. A., Arteel, G. E., Moreno, C., & Shah, V. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.007 · Cited by 49
Li, L., Zhou, J., Hao, X., Zhang, W., Yu, D., Xie, Y., Gu, J., & Zhu, T. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.557044 · Cited by 48
Yoo, E. R., Kim, D., Vazquez‐Montesino, L. M., Escober, J. A., Li, A. A., Tighe, S. P., Fernandes, C. T., Cholankeril, G. T., & Ahmed, A. (2020) · Liver International · doi:10.1111/liv.14374 · Cited by 48
Self-citationSundaram, V., Jalan, R., Shah, P., Singal, A. K., Patel, A., Wu, T. E., Noureddin, M., Mahmud, N., & Wong, R. J. (2020) · Hepatology · doi:10.1002/hep.31566 · Cited by 46
Highly Sensitive Two-Photon Lipid Droplet Tracker for In Vivo Screening of Drug Induced Liver Injury
Lee, H. W., Lee, I.-J., Lee, S., Kim, Y. R., & Kim, H. M. (2022) · ACS Sensors · doi:10.1021/acssensors.1c02679 · Cited by 46
Alcohol-associated Cirrhosis and Alcoholic Hepatitis Hospitalization Trends in the United States
Shirazi, F., Singal, A. K., & Wong, R. J. (2020) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001378 · Cited by 45
Palma, E., Riva, A., Moreno, C., Òdena, G., Mudan, S., Manyakin, N., Miquel, R., Degré, D., Trépo, E., Sancho‐Bru, P., et al. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14299 · Cited by 45
Silymarin: a review on paving the way towards promising pharmacological agent
Akhtar, M. N., Saeed, R., Saeed, F., Asghar, A., Ghani, S., Ateeq, H., Ahmed, A. A., Rasheed, A., Afzaal, M., Waheed, M., et al. (2023) · International Journal of Food Properties · doi:10.1080/10942912.2023.2244685 · Cited by 43
Self-citationPaik, J. M., Golabi, P., Younossi, Y., Saleh, N., Nhyira, A., & Younossi, Z. M. (2021) · Hepatology Communications · doi:10.1002/hep4.1673 · Cited by 42
Epidemiology: why is pleural disease becoming more common?
Bødtger, U. C. S., & Hallifax, R. (2020) · European Respiratory Society eBooks · doi:10.1183/2312508x.10022819 · Cited by 42
Magnitude of Nonalcoholic Fatty Liver Disease: Western Perspective
Samji, N. S., Verma, R., & Satapathy, S. K. (2019) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2019.05.001 · Cited by 45
Benhammou, J. N., Moon, A. M., Pisegna, J. R., Su, F., Vutien, P., Moylan, C. A., & Ioannou, G. N. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06457-2 · Cited by 40
Thiele, M. S., Johansen, S., Gudmann, N. S., Madsen, B. S., Kjærgaard, M., Nielsen, M. J., Leeming, D. J., Jacobsen, S., Bendtsen, F., Møller, S., et al. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16567 · Cited by 40
The steatotic liver disease burden paradox: unravelling the key role of alcohol
Torp, N., Israelsen, M. E., & Krag, A. A. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-01022-y · Cited by 39
Xu, H., Xiao, P., Zhang, F., Liu, T., & Gao, Y. (2022) · Liver International · doi:10.1111/liv.15312 · Cited by 37
Madsen, B. S., Thiele, M. S., Detlefsen, S., Kjærgaard, M., Møller, L. S., Trebicka, J., Nielsen, M. J., Gudmann, N. S., Leeming, D. J., Karsdal, M. A., et al. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16513 · Cited by 35
Stem Cell Therapies for Chronic Liver Diseases: Progress and Challenges
Li, T., Wang, Z.-R., Yao, W., Linghu, E., Wang, F., & Shi, L. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac053 · Cited by 38
Zhou, K., Dodge, J. L., Grab, J. D., Poltavskiy, E. A., & Terrault, N. A. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15803 · Cited by 33
Gau, S., Huang, K., Lee, C., Kuan, Y., Tsai, T., & Lee, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840106 · Cited by 34
Cholankeril, G. T., Gadiparthi, C., Yoo, E. R., Dennis, B. B., Li, A. A., Hu, M., Wong, K., Kim, D., & Ahmed, A. (2018) · Transplantation · doi:10.1097/tp.0000000000002471 · Cited by 32
Self-citationCharatcharoenwitthaya, P., Karaketklang, K., & Aekplakorn, W. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13001 · Cited by 31
Endogenous sex hormones and nonalcoholic fatty liver disease in US adults
Kim, D., Manikat, R., Cholankeril, G. T., & Ahmed, A. (2023) · Liver International · doi:10.1111/liv.15786 · Cited by 30
Self-citationCrismale, J. F., & Ahmad, J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i47.6799 · Cited by 30
Outpatient management of alcohol-related liver disease
Simonetto, D. A., Shah, V. H., & Kamath, P. S. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30415-7 · Cited by 30
Kim, D., Konyn, P., Cholankeril, G. T., Wong, R. J., Younossi, Z. M., Ahmed, A., Saab, S., Dhanasekaran, R., Mehta, N. J., Kanwa, F., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.007 · Cited by 29
Self-citationKim, D., Konyn, P., Cholankeril, G. T., Bonham, C. A., & Ahmed, A. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001151 · Cited by 29
Self-citationGlobal Burden of Nonalcoholic Fatty Liver Disease, 1990 to 2019
Jiang, W., Mao, X., Liu, Z., Zhang, T., Li, J., & Chen, X. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001739 · Cited by 29
Bataller, R. A., Cabezas, J., Aller, R., Cots, M. V., Abad, J., Albillos, A., Altamirano, J., Arias, M., Bañares, R., Caballería, J., et al. (2019) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2019.09.006 · Cited by 28
Thrombocytopenia in HIV infection.
Louache, F., & Vainchenker, W. (1994) · PubMed · Cited by 28
PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States
Wijarnpreecha, K., Scribani, M., Raymond, P., Harnois, D. M., Keaveny, A. P., Ahmed, A., & Kim, D. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15045 · Cited by 27
Self-citationPopa, A., Șirli, R., Popescu, A., Bâldea, V., Lupușoru, R., Bende, F., Cotrău, R., & Sporea, I. (2021) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2021.02.029 · Cited by 27
Adejumo, A., Kim, D., Iqbal, U., Yoo, E. R., Boursiquot, B. C., Cholankeril, G. T., Wong, R. J., Kwo, P. Y., & Ahmed, A. (2019) · Journal of Palliative Medicine · doi:10.1089/jpm.2019.0100 · Cited by 26
Self-citationPoliti, J., Guerras, J. M., Donat, M., Belza, M. J., Ronda, E., Barrio, G., & Regidor, E. (2021) · Hepatology · doi:10.1002/hep.32237 · Cited by 26
Validation of scores of PRO‐C3 to predict liver‐related events in alcohol‐related liver disease
Johansen, S., Israelsen, M. E., Villesen, I. F., Torp, N., Nielsen, M. J., Kjærgaard, M., Lindvig, K. P., Hansen, C. D., Andersen, P., Rasmussen, D. N., et al. (2023) · Liver International · doi:10.1111/liv.15595 · Cited by 25
Yu, C., Gao, J., Ge, X., Wang, X., Ding, Y., Tian, T., Xu, X. P., Guo, W., Wang, Q., Ge, Z., et al. (2022) · Nutrients · doi:10.3390/nu14183785 · Cited by 25
Mortality from chronic liver disease: Recent trends and impact of the COVID-19 pandemic
Fedeli, U., Amidei, C. B., Casotto, V., Grande, E., Saïa, M., Zanetto, A., & Russo, F. P. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i26.4166 · Cited by 25
Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study
Adejumo, A., Cholankeril, G. T., Iqbal, U., Yoo, E. R., Boursiquot, B. C., Concepcion, W., Kim, D., & Ahmed, A. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05759-4 · Cited by 25
Self-citationMedicaid Policy and Liver Transplant for Alcohol‐Associated Liver Disease
Lee, B. P., Vittinghoff, E., Pletcher, M. J., Dodge, J. L., & Terrault, N. A. (2019) · Hepatology · doi:10.1002/hep.31027 · Cited by 25
Pοlyzos, S. A., & Kountouras, J. (2019) · Helicobacter · doi:10.1111/hel.12588 · Cited by 24
Verma, M., Horrow, J., & Navarro, V. (2019) · Hepatology Communications · doi:10.1002/hep4.1328 · Cited by 23
Utility of Multiparametric CT for Identification of High-Risk NAFLD
Lubner, M. G., Graffy, P. M., Said, A., Watson, R. F., Zea, R. D., Malecki, K. M., & Pickhardt, P. J. (2021) · American Journal of Roentgenology · doi:10.2214/ajr.20.22842 · Cited by 23
Wang, Y., Huang, Y., Antwi, S. O., Taner, C. B., & Yang, L. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002561 · Cited by 22
Bae, J. Y. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17228307 · Cited by 24
Abboud, Y., Mathew, A. G., Meybodi, M. A., Medina‐Morales, E., Alsakarneh, S., Choi, C. J., Jiang, Y., & Pyrsopoulos, N. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.11.013 · Cited by 22
Stage-dependent expression of fibrogenic markers in alcohol-related liver disease
Sørensen, M. D., Thiele, M. S., Krag, A. A., Daniels, S. J., Leeming, D. J., Karsdal, M. A., & Detlefsen, S. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153798 · Cited by 21
Wei, L., & Huang, Y. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1588112 · Cited by 21
Applications of multiple reaction monitoring targeted proteomics assays in human plasma
Kontostathi, G., Makridakis, M., Zoidakis, J., & Vlahou, A. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1615448 · Cited by 21
Rashid, Z., Woldesenbet, S., Khalil, M., Iyer, S., Khan, M. M. M., Altaf, A., Munir, M. M., Catalano, G., Mumtaz, K., & Pawlik, T. M. (2024) · Liver International · doi:10.1111/liv.16132 · Cited by 20
Self-citationGlobal burden trends and forecasts for MAFLD in adolescents and young adults from 1990 to 2021
Ruan, S., Huang, L., Song, J. Y., Yi, Z., Sun, W., Zhou, F., Feng, C., Du, G., Xie, J., Lu, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-98489-9 · Cited by 21
A Study on the Temporal Trends in the Etiology of Cirrhosis of Liver in Coastal Eastern Odisha
Mishra, D., Dash, K. R., Khatua, C., Panigrahi, S., Parida, P. K., Behera, S. K., Barik, R. K., Pradhan, S., Sahu, S. K., Thakur, B., et al. (2020) · Euroasian Journal of Hepato-Gastroenterology · doi:10.5005/jp-journals-10018-1312 · Cited by 20
Dennis, B. B., Naji, L., Jajarmi, Y., Ahmed, A., & Kim, D. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i29.4818 · Cited by 20
Self-citationYuan, L., Hanlon, C. L., Terrault, N. A., Alqahtani, S. A., Tamim, H., Lai, M., & Saberi, B. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001591 · Cited by 20
MMP10 alleviates non-alcoholic steatohepatitis by regulating macrophage M2 polarization
Chang, L., Gao, J., Yu, Y., Liao, B., Zhou, Y., Zhang, J., Ma, X., Hou, W., Zhou, T., & Xu, Q. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111045 · Cited by 20
Guedes, T. P., Fragoso, P., Lemos, C., Garrido, M., Silva, J., Falcão, D., Maia, L., Moreira, T., Ferreira, J. M., & Pedroto, I. (2019) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000503074 · Cited by 19
Haque, L., Zuluaga, P., Muga, R., & Fuster, D. (2024) · Addiction Science & Clinical Practice · doi:10.1186/s13722-024-00448-8 · Cited by 18
Duffell, E. F., Cortez‐Pinto, H., Simonova, M., Dalgård, O., Dahl, E. H., de Martel, C., Mozalevskis, A., Buti, M., Pavlova, S., Hadzhilova, T., et al. (2021) · Journal of Viral Hepatitis · doi:10.1111/jvh.13545 · Cited by 17
Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality
Kim, D., Manikat, R., Shaikh, A., Cholankeril, G., & Ahmed, A. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14087 · Cited by 17
Self-citationTrends in alcohol use and alcoholic liver disease in South Korea: a nationwide cohort study
Yoo, J., Lee, D. H., Chang, Y. W., Jo, H., Cho, Y. Y., Lee, S., Kim, L. Y., & Jang, J. Y. (2024) · BMC Public Health · doi:10.1186/s12889-024-19321-z · Cited by 17
Hepatocellular Carcinoma-Related Mortality in the USA, 1999–2018
Ramani, A., Tapper, E. B., Griffin, C., Shankar, N., Parikh, N. D., & Asrani, S. K. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07433-8 · Cited by 17
Lam, J. O., Hurley, L. B., Lai, J. B., Saxena, V., Seo, S., Chamberland, S., Quesenberry, C. P., Champsi, J. H., Ready, J. B., Chiao, E. Y., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0742 · Cited by 17
Metadata
- Authors
- Kim, D., Li, A. A., Gadiparthi, C., Khan, M. A., Cholankeril, G., Glenn, J. S., & Ahmed, A.
- Affiliations
- Stanford Medicine (US)
- University of Tennessee Health Science Center (US)
- Corresponding author
- Kim, Donghee
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 155
- Issue
- 4
- Pages
- 1154-1163.e3
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC6467699
- OpenAlex
- W2884426912
- Cited by
- 223
- References
- 38
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 21 · 2023: 23 · 2022: 30 · 2021: 34 · 2020: 40 · 2019: 36 · 2018: 5
- FWCI
- 18.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007056)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- chronic liver disease, hepatitis C virus, alcoholic liver disease, non-alcoholic fatty liver disease, hepatitis B virus, mortality trends, direct-acting antivirals, age-standardized mortality rates, racial and ethnic disparities, minority groups, mortality burden, annual percent change, ICD-10
- MeSH terms
- Adult, Antiviral Agents, Asian, Black or African American, Cause of Death, Female, Hispanic or Latino, Humans, Liver Diseases, Alcoholic, Male, Middle Aged, Risk Factors, Time Factors, United States, Prevalence, Age Distribution, Censuses, Hepatitis B, Chronic, Hepatitis C, Chronic, White People, Health Status Disparities, Young Adult, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
